NCT07747389 — "A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder" trial site landscape

Public-registry site landscape for NCT07747389, “A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder”, a Depressive Disorder, Major study sponsored by Intra-Cellular Therapies, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07747389 (registry record)
Study title	A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder
Official title	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Fixed Doses of Lumateperone Administered as Monotherapy in Participants With Major Depressive Disorder and an Open-label Long-term Extension Treatment With Lumateperone
Sponsor	Intra-Cellular Therapies, Inc.
Condition(s)	Depressive Disorder, Major
Phase	PHASE3
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07747389.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07747389 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →